Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-009403
Filing Date
2015-02-04
Accepted
2015-02-04 16:14:24
Documents
1
Period of Report
2015-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9533
  Complete submission text file 0001209191-15-009403.txt   11113
Mailing Address 800 BOYLSTON STREET SUITE 1555 BOSTON MA 02199
Business Address 800 BOYLSTON STREET SUITE 1555 BOSTON MA 02199 617-351-2590
Longwood Fund II, L.P. (Reporting) CIK: 0001543245 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36812 | Film No.: 15575609

Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Issuer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations